Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mitochon Pharmaceuticals, Inc. logo — Harnessing the Power of Mitochondria to Create Resilient, Pr...

Mitochon Pharmaceuticals, Inc.

Harnessing the Power of Mitochondria to Create Resilient, Protective Cells in Neurodegeneration and Aging

Founded 2014 United States United States 4 employees Series Unknown Total: $2.33M Biopharma, Biotechnology +1

General Information

Company Name Mitochon Pharmaceuticals, Inc.
Founded Year 2014
Location United States United States +1
Employees 4
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Mitochon Pharmaceuticals, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mitochon Pharmaceuticals, Inc.

Mitochon Pharmaceuticals, Inc. is a biotech startup founded in 2014, headquartered in the United States. The company's slogan "Harnessing the Power of Mitochondria to Create Resilient, Protective Cells in Neurodegeneration and Aging" reflects its focus on developing drugs that target mitochondria to address serious diseases with unmet medical needs. Their clinical programs primarily target neurodegenerative diseases such as Huntington’s Disease, Multiple Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s, Parkinson, and Traumatic Brain Injury (TBI). Mitochon's approach is centered around correcting mitochondrial physiology to pave the way for disease-modifying therapies. Their platform is based on mitochondrial enhancers that specifically target the mitochondria, delivering brain-penetrating therapy to stimulate compensatory pathways. The company's mechanism of action can be found on their website (MOA: link). Notably, Mitochon has received $1.60M in a Venture Round investment from Ben Franklin Technology Partners of Southeastern Pennsylvania in May 17, 2016. Led by industry executives with over 80 years of combined experience, the company is passionately committed to advancing breakthrough drug therapies for devastating diseases within the Biopharma, Biotechnology, and Pharmaceutical industries.

Taxonomy: biotech, mitochondria, neurodegenerative diseases, drug development, neuroprotection, mitochondrial enhancers, clinical-stage, brain penetrating therapy, disease modifying therapies, executive team, pharmaceuticals, aging, free radical production, ATP production, mechanism of action

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
17 May 2016
Debt Financing •••••• - 29 Apr 2016
Seed Round •••••• 1
Investor
05 Nov 2014

Mitochon Pharmaceuticals, Inc. Alternatives & Competitors

Mitochon Pharmaceuticals, Inc. vs
Reneo Pharmaceuticals
Reneo Pharmaceuticals United States

Reneo Pharmaceuticals is now OnKure Therapeutics, Inc.!

Post Ipo Equity
16 employees
Biotechnology, Pharmaceutical
Mitochon Pharmaceuticals, Inc. vs
Partikula LLC
Partikula LLC United States

Partikula leverages its exclusive chemical engineering technologies to create compounds that specifi...

Series Unknown
2-10 employees
Biotechnology, Health Care
Mitochon Pharmaceuticals, Inc. vs
Minovia Therapeutics
Minovia Therapeutics Israel

A clinical-stage international biotechnology research company focused on treatment innovation for mi...

28 employees
Also compare with: Mitochon Pharmaceuticals, Inc. vs Clene Nanomedicine, Inc. Clene Nanomedicine, Inc.

FAQ About Mitochon Pharmaceuticals, Inc.

Harnessing the Power of Mitochondria to Create Resilient, Protective Cells in Neurodegeneration and Aging
Mitochon Pharmaceuticals, Inc. was founded in 2014.
Mitochon Pharmaceuticals, Inc. is headquartered in United States.
Mitochon Pharmaceuticals, Inc. operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
Mitochon Pharmaceuticals, Inc. has approximately 4 employees.
Mitochon Pharmaceuticals, Inc. has completed 3 funding rounds, raising a total of $2.33M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Mitochon Pharmaceuticals, Inc. include Reneo Pharmaceuticals, Partikula LLC, Minovia Therapeutics , RiboNova, Inc., Eikonizo Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mitochon Pharmaceuticals, Inc. and Reneo Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mitochon Pharmaceuticals, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy